Saskia Tamminga
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Saskia Tamminga has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Lidewij Henneman
Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands
3 shared publicationsMartina C. Cornel
Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands
3 shared publicationsMerel van Maarle
Academic Medical Centre, Amsterdam, the Netherlands
2 shared publicationsCaterina M. Bilardo
Department of Fetal Medicine and Prenatal Diagnosis, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands
1 shared publicationCees B.M. Oudejans
Department of Clinical chemistry, VU University Medical Center, Amsterdam, the Netherlands
1 shared publicationE. J. ( Joanne) Verweij
Department of Obstetrics and Gynaecology, Leiden University Medical Center, Leiden, the Netherlands
1 shared publication
Latest Publications
- Open Access
- 28 February 2017
- Published by Wiley in Prenatal Diagnosis
- Vol. 37 (4) , 412-415
What do people want to know about NIPT? Content analysis of questions emailed to national NIPT information websites
What's already known about this topic? Several countries, including the Netherlands, have implemented non‐invasive prenatal testing (NIPT) in their national prenatal screening program Access to relevant online health information is important as it increases informed decision making What does this study add? Visitors of national NIPT websites mostly request more information about testing beyond the currently available NIPT: a broader range of disorders (such as monogenic disorders) and increasing target group eligibility (such as low‐risk or twin pregnancies) © 2017 The Authors. Prenatal Diagnosis published by John Wiley & Sons, Ltd.
- 28 February 2017
- Published by Wiley in Prenatal Diagnosis
- Vol. 37 (4) , 412-415
Open AccessWhat do people want to know about NIPT? Content analysis of questions emailed to national NIPT information websites
What's already known about this topic? Several countries, including the Netherlands, have implemented non‐invasive prenatal testing (NIPT) in their national prenatal screening program Access to relevant online health information is important as it increases informed decision making What does this study add? Visitors of national NIPT websites mostly request more information about testing beyond the currently available NIPT: a broader range of disorders (such as monogenic disorders) and increasing target group eligibility (such as low‐risk or twin pregnancies) © 2017 The Authors. Prenatal Diagnosis published by John Wiley & Sons, Ltd.
- 1 January 2016
- Published by Elsevier
- Vol. 74, 63-102
Maternal Plasma DNA and RNA Sequencing for Prenatal Testing
- 1 January 2016
- Published by Elsevier
- Vol. 74, 63-102
Maternal Plasma DNA and RNA Sequencing for Prenatal Testing
- Open Access
- 28 September 2015
- Published by Wiley in Prenatal Diagnosis
- Vol. 35 (13) , 1316-1323
Changing to NIPT as a first-tier screening test and future perspectives: opinions of health professionals
Objective The aim of this study was to investigate health professionals' opinions toward offering noninvasive prenatal testing (NIPT) as first-tier screening test regardless of pregnant women's risk, and toward a potential broader range of disorders. Methods A questionnaire completed by obstetric health professionals (n = 240) after an in-service NIPT training in the West and North of the Netherlands. Results The majority (72%) of respondents favored replacing first-trimester combined test (FCT) by NIPT, although 43% preferred to maintain nuchal translucency measurement. Many respondents believed that replacing FCT by NIPT would only have advantages (57%), would lead to more pregnant women opting for prenatal testing (69%), and would simplify counseling (47%). Differences in attitudes toward counseling between health professionals were observed. When considering NIPT to screen for broader range of disorders, the majority (92%) thought that this should include disorders characterized by neonatal death, whereas 52% of the respondents favored testing for fetomaternal risk factors. Overall, 46% thought screening should be offered as a fixed list of disorders. Conclusion Most health professionals favor NIPT instead of FCT but prefer to maintain nuchal translucency measurement. If NIPT becomes available as a first-tier screening test, attention remains necessary to ensure that pregnant women make well-informed decisions in line with the aim of prenatal screening. © 2015 John Wiley & Sons, Ltd.
- 28 September 2015
- Published by Wiley in Prenatal Diagnosis
- Vol. 35 (13) , 1316-1323
Open AccessChanging to NIPT as a first-tier screening test and future perspectives: opinions of health professionals
Objective The aim of this study was to investigate health professionals' opinions toward offering noninvasive prenatal testing (NIPT) as first-tier screening test regardless of pregnant women's risk, and toward a potential broader range of disorders. Methods A questionnaire completed by obstetric health professionals (n = 240) after an in-service NIPT training in the West and North of the Netherlands. Results The majority (72%) of respondents favored replacing first-trimester combined test (FCT) by NIPT, although 43% preferred to maintain nuchal translucency measurement. Many respondents believed that replacing FCT by NIPT would only have advantages (57%), would lead to more pregnant women opting for prenatal testing (69%), and would simplify counseling (47%). Differences in attitudes toward counseling between health professionals were observed. When considering NIPT to screen for broader range of disorders, the majority (92%) thought that this should include disorders characterized by neonatal death, whereas 52% of the respondents favored testing for fetomaternal risk factors. Overall, 46% thought screening should be offered as a fixed list of disorders. Conclusion Most health professionals favor NIPT instead of FCT but prefer to maintain nuchal translucency measurement. If NIPT becomes available as a first-tier screening test, attention remains necessary to ensure that pregnant women make well-informed decisions in line with the aim of prenatal screening. © 2015 John Wiley & Sons, Ltd.